Cite Filings / CTKB / 0000950170-22-016500

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Cytek Biosciences, Inc. Filed 2022-08-10 Acc 0000950170-22-016500

Documents 1

10-Q Quarterly Report , ctkb-20220630.htm

Around this filing

2022-11-09 10-Q Quarterly Report
2022-08-10 4 President and CEO sold 20,000 shares at $15.09 ($301,800)
2022-08-10 8-K Results of operations
2022-08-10 10-Q Quarterly Report
2022-08-03 SC 13G/A Amended Statement of Ownership
2022-08-03 4 Chief Financial Officer sold 3,500 shares at $12.80 ($44,800)
2022-05-12 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading ctkb-20220630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…